Low bone mineral density in children with Crohn's disease

被引:11
作者
Bourges, O
Dorgeret, S
Alberti, C
Hugot, JP
Sebag, G
Cézard, JP
机构
[1] Hop Robert Debre, AP HP, Serv Gastroenterol & Nutr Pediat, F-75019 Paris, France
[2] Hop Robert Debre, AP HP, Serv Radiol, F-75019 Paris, France
[3] Hop Robert Debre, AP HP, Serv Sante Publ, F-75019 Paris, France
来源
ARCHIVES DE PEDIATRIE | 2004年 / 11卷 / 07期
关键词
dual-photon absorptiometry; corticoids; therapeutic use; bone mineral density; Crohn's disease; osteopenia; osteoporosis; child;
D O I
10.1016/j.arcped.2004.02.027
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Recent studies have reported low bone mineral density in children with Crohn's disease. The aims of this retrospective study were to quantify its frequency and to search for risk factors. Population and methods. - Bone mineral density of 29 children with Crohn's disease was measured by dual-energy X-ray absorptiometry. All the children were taking calcium and vitamin D, during all the follow-up. Results. - Osteoporosis (Z-score less than or equal to -2.5 S.D.) was found in 38% of the children, and osteopenia in 38% (Z-score between -1 and -2.5 S.D.). Low bone mineral density was correlated with age, suggesting it begins with puberty. Daily corticosteroid exposure was significantly higher for patients with osteoporosis. Disease severity measured with Harvey-Bradshaw index and exposure to immunosuppressive drugs were almost statistically significant. Sex, height, duration and site of disease, nutritional assistance exposure were not associated with low bone mineral density. Conclusion. - This study confirms the high frequency of low bone mineral density in children with Crohn's disease, mainly during puberty. Corticosteroid exposure is a risk factor, and the disease severity, a probable one (non significant). New treatment strategy has to be defined to prevent and to treat this complication. (C) 2004 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:800 / 806
页数:7
相关论文
共 23 条
[1]   Metabolic bone disease in adults with inflammatory bowel disease [J].
Adachi, JD ;
Rostom, A .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (03) :200-211
[2]   Inflammatory bowel disease and osteoporosis [J].
Andreassen, H ;
Rungby, J ;
Dahlerup, JF ;
Mosekilde, L .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (12) :1247-1255
[3]  
BENHAMOU CL, 2000, OSTEOPOROSES
[4]   Bone mineral density and nutritional status in children with chronic inflammatory bowel disease [J].
Boot, AM ;
Bouquet, J ;
Krenning, EP ;
Keizer-Schrama, SMPFD .
GUT, 1998, 42 (02) :188-194
[6]   OSTEOPENIA IN CROHNS-DISEASE [J].
COWAN, FJ ;
PARKER, DR ;
JENKINS, HR .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (03) :255-256
[7]   Inflammatory bowel disease and predisposition to osteopenia [J].
Cowan, FJ ;
Warner, JT ;
Dunstan, FDJ ;
Evans, WD ;
Gregory, JW ;
Jenkins, HR .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (04) :325-329
[8]   Bone mineral density assessment in children with inflammatory bowel disease [J].
Gokhale, R ;
Favus, MJ ;
Karrison, T ;
Sutton, MM ;
Rich, B ;
Kirschner, BS .
GASTROENTEROLOGY, 1998, 114 (05) :902-911
[9]   INCIDENCE OF INFLAMMATORY BOWEL-DISEASE IN NORTHERN FRANCE (1988-1990) [J].
GOWERROUSSEAU, C ;
SALOMEZ, JL ;
DUPAS, JL ;
MARTI, R ;
NUTTENS, MC ;
VOTTE, A ;
LEMAHIEU, M ;
LEMAIRE, B ;
COLOMBEL, JF ;
CORTOT, A .
GUT, 1994, 35 (10) :1433-1438
[10]   Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease [J].
Haderslev, KV ;
Tjellesen, L ;
Sorensen, HA ;
Staun, M .
GASTROENTEROLOGY, 2000, 119 (03) :639-646